Clinigence Holdings Inc (NUTX)
NASDAQ:NUTX
Total Valuation
Clinigence Holdings has a market cap or net worth of $703.25M. The enterprise value is $766.73M.
Market Cap$703.25M
Enterprise Value$766.73M
Share Statistics
Clinigence Holdings has 6,968,350 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding6,968,350
Owned by Insiders28.77%
Owned by Institutions16.80%
Financial Efficiency
Clinigence Holdings’s return on equity (ROE) is 0.21 and return on invested capital (ROIC) is 25.91%.
Return on Equity (ROE)0.21
Return on Assets (ROA)0.08
Return on Invested Capital (ROIC)25.91%
Return on Capital Employed (ROCE)0.36
Revenue Per Employee1.09M
Profits Per Employee225.45K
Employee Count800
Asset Turnover0.95
Inventory Turnover150.38
Valuation Ratios
The current PE Ratio of Clinigence Holdings is 15.6. Clinigence Holdings’s PEG ratio is 1.77.
PE Ratio15.6
PS Ratio1.26
PB Ratio3.35
Price to Fair Value3.35
Price to FCF4.49
Price to Operating Cash Flow2.73
PEG Ratio1.77
Income Statement
In the last 12 months, Clinigence Holdings had revenue of 875.26M and earned 70.79M in profits. Earnings per share was 11.13.
Revenue875.26M
Gross Profit444.28M
Operating Income275.63M
Pretax Income244.78M
Net Income70.79M
EBITDA296.15M
Earnings Per Share (EPS)11.13
Cash Flow
In the last 12 months, operating cash flow was 248.13M and capital expenditures -2.53M, giving a free cash flow of 245.60M billion.
Operating Cash Flow248.13M
Free Cash Flow245.60M
Free Cash Flow per Share35.24
Dividends & Yields
Clinigence Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.32
52-Week Price Change33.86%
50-Day Moving Average110.15
200-Day Moving Average117.56
Relative Strength Index (RSI)50.67
Average Volume (3m)205.35K
Important Dates
Clinigence Holdings upcoming earnings date is May 19, 2026, TBA (Confirmed).
Last Earnings DateMar 5, 2026
Next Earnings DateMay 19, 2026
Ex-Dividend Date―
Financial Position
Clinigence Holdings as a current ratio of 3.41, with Debt / Equity ratio of 106.66%
Current Ratio3.41
Quick Ratio3.39
Debt to Market Cap0.04
Net Debt to EBITDA0.56
Interest Coverage Ratio12.40
Taxes
In the past 12 months, Clinigence Holdings has paid 64.42M in taxes.
Income Tax64.42M
Effective Tax Rate0.26
Enterprise Valuation
Clinigence Holdings EV to EBITDA ratio is 4.28, with an EV/FCF ratio of 5.17.
EV to Sales1.45
EV to EBITDA4.28
EV to Free Cash Flow5.17
EV to Operating Cash Flow5.11
Balance Sheet
Clinigence Holdings has $185.57M in cash and marketable securities with $351.39M in debt, giving a net cash position of -$165.82M billion.
Cash & Marketable Securities$185.57M
Total Debt$351.39M
Net Cash-$165.82M
Net Cash Per Share-$23.80
Tangible Book Value Per Share$57.94
Margins
Gross margin is 50.76%, with operating margin of 31.49%, and net profit margin of 8.09%.
Gross Margin50.76%
Operating Margin31.49%
Pretax Margin27.97%
Net Profit Margin8.09%
EBITDA Margin33.84%
EBIT Margin31.49%
Analyst Forecast
The average price target for Clinigence Holdings is $225.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$225.00
Price Target Upside22.21% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast236.03%
EPS Growth Forecast―